Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Vitamin D in allergic disorders.
Pathogenesis of immune-mediated neuropathies.
Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.
Statins in neurological disorders: An overview and update.
Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Influence of Cognitive Function on Speech and Articulation Rate in Multiple Sclerosis.
Emerging subspecialties in neurology: neuroimmunology.
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
DNA Damage, DNA Repair, Aging, and Neurodegeneration.
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.
Early Postnatal Myelin Content Estimate of White Matter via T1w/T2w Ratio.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
An MRI review of acquired corpus callosum lesions.
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »